Here is a valid rebuttal, when biotech stock gets FDA approval, they always jump by 50-100%+ (depending the product, IMO, RAP is such a product and there will be at least 100% spike) so why would they sell when after the approval, the revenue will be worth at least $100M+ and with minimal operating cost and expenditure of probably less than $5M (if that), let alone the patent IP by itself will also be worth at least $200-300M+ you would think?
Hence, over time, RAP will be a billion dollar company.
Yes some might sell some of those escrow shares but this will be soaked up as there is less risk associated with RAP being a billion dollar company over time after FDA approval but like I said, the good result from the FDA clinical trials and FDA approval isn't a given and market is trading it as such. If it was a given, most will be putting their house on it right now, even you....wouldn't you?
- Forums
- ASX - By Stock
- Telehealth on the rise
Here is a valid rebuttal, when biotech stock gets FDA approval,...
-
- There are more pages in this discussion • 2,934 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
MTL
Mantle Minerals' Nick Poll talks to HotCopper on finding gold grades up to 3.57g/t at Mt Berghaus
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
Add RAP (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable